Sulfonium Salt Reagents for the Introduction of Deuterated Alkyl Groups in Drug Discovery
Angewandte Chemie International Edition · 27.11.2023 · 62 (48)
DOI: 10.1002/anie.202311058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 27.09.2023. Verfasst von Kazuho Ban und 9 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Osaka University, 1-6, Yamada-oka, Suita, Osaka, 565-0871, Japan. Hauptthemen laut MEDLINE: Salts, Cytochrome P-450 Enzyme System. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: JSPS KAKENHI, JST SPRING, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
The pharmacokinetics of pharmaceutical drugs can be improved by replacing C−H bonds with the more stable C−D bonds at the α‐position to heteroatoms, which is a typical metabolic site for cytochrome P450 enzymes. However, the application of deuterated synthons is limited. Herein, we established a novel concept for preparing deuterated reagents for the successful synthesis of complex drug skeletons with deuterium atoms at the α‐position to heteroatoms. ( d n ‐Alkyl)diphenylsulfonium salts prepared from the corresponding nondeuterated forms using inexpensive and abundant D 2 O as the deuterium source with a base, were used as electrophilic alkylating reagents. Additionally, these deuterated sulfonium salts were efficiently transformed into d n ‐alkyl halides and a d n ‐alkyl azide as coupling reagents and a d n ‐alkyl amine as a nucleophile. Furthermore, liver microsomal metabolism studies revealed deuterium kinetic isotope effects (KIE) in 7‐( d 2 ‐ethoxy)flavone. The present concept for the synthesis of deuterated reagents and the first demonstration of a KIE in a d 2 ‐ethoxy group will contribute to drug discovery research based on deuterium chemistry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Pharmaceutical Sciences, Osaka University, 1-6, Yamada-oka, Suita, Osaka, 565-0871, Japan.
- Department of Formulation Design and Pharmaceutical Technology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki, Osaka, 569-1094, Japan.
- Deuterium Science Research Unit, Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Yoshida, Sakyo-ku, Kyoto, 606-8501, Japan.
ORCID-Profile: Yoshinari Sawama
Förderung
- JSPS KAKENHI
- JST SPRING
- Japan Society for the Promotion of Science
- Life Science and Drug Discovery (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED
- Takeda Science Foundation
- the Mochida Memorial Foundation for Medical and Pharmaceutical Research
Zitieren
APA
Ban, K., Imai, K., Oyama, S., Tokunaga, J., Ikeda, Y., Uchiyama, H., Kadota, K., Tozuka, Y., Akai, S., & Sawama, Y. (2023). Sulfonium Salt Reagents for the Introduction of Deuterated Alkyl Groups in Drug Discovery. Angewandte Chemie International Edition, 62(48). https://doi.org/10.1002/anie.202311058
Vancouver
Ban K, Imai K, Oyama S, Tokunaga J, Ikeda Y, Uchiyama H, et al. Sulfonium Salt Reagents for the Introduction of Deuterated Alkyl Groups in Drug Discovery. Angewandte Chemie International Edition. 2023;62(48). doi:10.1002/anie.202311058
BibTeX
@article{Ban2023,
author = {Ban, Kazuho and Imai, Keisuke and Oyama, Shuki and Tokunaga, Jin and Ikeda, Yui and Uchiyama, Hiromasa and Kadota, Kazunori and Tozuka, Yuichi and Akai, Shuji and Sawama, Yoshinari},
title = {Sulfonium Salt Reagents for the Introduction of Deuterated Alkyl Groups in Drug Discovery},
journal = {Angewandte Chemie International Edition},
year = {2023},
volume = {62},
number = {48},
doi = {10.1002/anie.202311058}
}
EUVIMED